Cargando…

Pazopanib-Induced Alopecia, an Underestimated Toxicity?

Pazopanib and sunitinib are treatment options for metastatic renal cell cancer (mRCC), with similar efficacy, and minor differences in their toxicity profile. Our experience has suggested that pazopanib-induced alopecia may be a potentially significant but previously under-reported toxicity. For thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biondo, Andrea, Alexander, Helen, Khabra, Komel, Pickering, Lisa, Gore, Martin, Larkin, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426820/ https://www.ncbi.nlm.nih.gov/pubmed/26029668 http://dx.doi.org/10.3389/fonc.2015.00112

Ejemplares similares

Observation as a treatment strategy for advanced renal cell carcinoma—a call for prospective validation
por: Fisher, Rosalie, et al.
Publicado: (2012)

Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases
por: Seifert, Heike, et al.
Publicado: (2015)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019)

The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
por: Booth, Laurence, et al.
Publicado: (2019)

Pazopanib as Treatment Option for Pseudomyogenic Hemangioendothelioma: A Case Report
por: Alhanash, Ali, et al.
Publicado: (2022)

Pazopanib and pancreatic toxicity: a case report
por: Russano, Marco, et al.
Publicado: (2015)

Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature
por: Tsavaris, Onoufrios, et al.
Publicado: (2018)

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
por: Vasudev, Naveen S., et al.
Publicado: (2011)

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
por: Thanopoulou, Eirini, et al.
Publicado: (2014)

Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model
por: Akagunduz, Baran, et al.
Publicado: (2020)

Pazopanib and Statin-Induced Rhabdomyolysis
por: Logue, Jennifer M., et al.
Publicado: (2017)

Phototoxic Reaction Induced by Pazopanib
por: Udompanich, Siriorn, et al.
Publicado: (2018)

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
por: Bongiovanni, Alberto, et al.
Publicado: (2020)

Low‐cost Kinect Version 2 imaging system for breath hold monitoring and gating: Proof of concept study for breast cancer VMAT radiotherapy
por: Edmunds, David M., et al.
Publicado: (2018)

Progressive multifocal leukoencephalopathy associated with chemotherapy induced lymphocytopenia in solid tumors – case report of an underestimated complication
por: Mayr, Patrick, et al.
Publicado: (2022)

Recurrent retroperitoneal soft tissue sarcoma showing drastic reduction after pazopanib administration accompanied by severe liver dysfunction
por: Okubo, Kazuki, et al.
Publicado: (2018)

A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas
por: Russo, Ida, et al.
Publicado: (2020)

Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital
por: Thanopoulou, Eirini, et al.
Publicado: (2015)

Pazopanib induced hand-foot syndrome
por: Sundriyal, Deepak, et al.
Publicado: (2015)

Pazopanib-Induced Severe Acute Pancreatitis
por: Kawakubo, Kazumichi, et al.
Publicado: (2015)

5-FU-induced cardiac toxicity - an underestimated problem in radiooncology?
por: Steger, Felix, et al.
Publicado: (2012)

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting
por: Nikic, Predrag, et al.
Publicado: (2022)

Case of an Incidentally Found Squamous Cell Carcinoma of the Tonsil: Are We Underestimating Its Incidence?
por: Parsi, Meghana
Publicado: (2019)

Underestimations in the In Silico-Predicted Toxicities of V-Agents
por: Pampalakis, Georgios
Publicado: (2023)

Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study
por: Kinoshita, Takayuki, et al.
Publicado: (2019)

Reversible Posterior Leukoencephalopathy Syndrome Induced by Pazopanib
por: Chelis, Leonidas, et al.
Publicado: (2012)

Pazopanib-induced Endothelial Injury with Podocyte Changes
por: Maruyama, Keisuke, et al.
Publicado: (2017)

Interstitial Lung Disease Induced by Pazopanib Treatment
por: Ide, Shotaro, et al.
Publicado: (2017)

Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?
por: Ucar, Gokhan, et al.
Publicado: (2020)

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2016)

An Underestimated Toxicity Radiation-Induced Hypothyroidism in Patients Multimodally Treated for Breast Cancer
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Rapid and life-threatening heart failure induced by pazopanib
por: Wang, Haotong, et al.
Publicado: (2018)

Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010)

Tension Pneumothorax: Is it Sarcoma or Pazopanib?
por: Sebanayagam, Vinoja, et al.
Publicado: (2020)

Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis
por: Katz, D., et al.
Publicado: (2016)

Evaluation of Acute Locoregional Toxicity in Patients with Breast Cancer Treated with Adjuvant Radiotherapy in Combination with Pazopanib
por: Goyal, Sharad, et al.
Publicado: (2012)

Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring EWSR1::CREM fusion: clinicopathological series of two cases and literature review
por: Campoverde, Leticia, et al.
Publicado: (2023)

Prevention of Pazopanib-Induced Prolonged Cardiac Repolarization and Proarrhythmic Effects
por: Akman, Tulay, et al.
Publicado: (2014)

Pazopanib, a promising option for the treatment of aggressive fibromatosis
por: Szucs, Zoltan, et al.
Publicado: (2017)

Pazopanib: Approval for Soft-Tissue Sarcoma
por: Nguyen, Diana T., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f3c6iqcd09h9monnbp0p4f7n9f